股价大跌，一度冲上热搜！有人称“喝了一晚上睡不着”，霸王茶姬发长文回应“咖啡因”争议

Core Viewpoint - Bawang Chaji is facing public scrutiny due to concerns over caffeine content in its beverages, leading to significant stock price fluctuations and discussions on social media platforms [2][4][21]. Group 1: Caffeine Controversy - A social media post claimed that high-caffeine drinks like Bawang Chaji's are akin to "quasi-drugs," sparking widespread debate among consumers [2]. - Bawang Chaji's stock fell over 15% on December 26, reaching a record low, before closing down 2.54% at $11.90 per share, with a total market value of $22.1 billion [4][22]. - The company responded to the controversy, asserting that the claims are malicious and have initiated legal action to protect its reputation [4]. Group 2: Product Information and Adjustments - Bawang Chaji disclosed that a large cup of its "Boya Juexian" drink contains 117.2 mg of caffeine, while the "Light Caffeine Boya Juexian" variant has 55.4 mg, significantly lower than the 184.4 mg in "Wanli Mulian" and 175.8 mg in "Yiqi Hongchen" [21]. - The company emphasizes that its tea drinks contain natural caffeine and are rich in other beneficial compounds, promoting a balanced consumption experience [14][17]. Group 3: Financial Performance - In Q3 2025, Bawang Chaji reported a total GMV of 79.3 billion yuan and net revenue of 32.08 billion yuan, with a net profit of 5.03 billion yuan [22]. - Despite the growth in overseas business, domestic same-store sales declined by 27.9%, attributed to increased competition and high base effects from the previous year [23]. - The company plans to focus on product innovation and strategic brand investments to enhance market share and operational efficiency [23].